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During the summer of 2014, all the pre-requisites for 
autochthonous transmission of chikungunya virus are 
present in southern France: a competent vector, Aedes 
albopictus, and a large number of travellers returning 
from the French Caribbean islands where an outbreak 
is occurring. We describe the system implemented for 
the surveillance of chikungunya and dengue in main-
land France. From 2 May to 4 July 2014, there were 126 
laboratory-confirmed imported chikungunya cases in 
mainland France.
In November 2013, locally acquired cases of chikungu-
nya were laboratory-confirmed in the French Caribbean 
island of Saint Martin [1]. The chikungunya virus 
rapidly spread in the surrounding French territories 
(Martinique, Guadeloupe, Saint Barthélemy and French 
Guiana) in December 2013 and then in most of the 
islands of the Caribbean [2,3]. By 15 June 2014, there 
were more than 80,000 clinically compatible cases in 
the French Caribbean Islands, based on the estima-
tion of the sentinel surveillance [4]. Given the epidemic 
situation in the French Caribbean, and due to the large 
amount of travel between mainland France and the 
Caribbean, it is expected that a large number of chi-
kungunya cases will be imported to mainland France in 
2014.
During the summer of 2014, all the pre-requisites for 
autochthonous transmission of chikungunya virus, and 
to a lesser extent, dengue virus, will then be present 
in southern France: a competent vector [5], a large 
number of viraemic travellers, and favourable climatic 
conditions for mosquito reproduction and viral replica-
tion in the mosquitoes. The likelihood of chikungunya 
transmission in mainland France is therefore particu-
larly high.
Surveillance of chikungunya and dengue in 
mainland France
Chikungunya and dengue are mosquito-borne viral 
diseases, transmitted by Aedes mosquitoes, in par-
ticular Aedes aegypti and Aedes albopictus, the latter 
being present in Europe [6,7]. Since it was identified 
in 2004 in the French administrative district of Alpes-
Maritimes, Ae. albopictus has continued to spread in 
southern France [8,9].
Since 2006, in response to Ae.  albopictus establish-
ment in southern France, the French Ministry of Health 
has implemented a dengue and chikungunya prepared-
ness and response plan to monitor and prevent the risk 
of dissemination of the two viruses in mainland France 
[10]. Because the two diseases present a number of 
similarities regarding the clinical and entomological 2 www.eurosurveillance.org
features, a common system has been set up compris-
ing entomological and epidemiological surveillance.
Entomological surveillance for 
chikungunya and dengue
The entomological surveillance is operated by public 
local structures of mosquito control, under the coordi-
nation and responsibility of the Ministry of Health.
The presence and the spread of Ae.  albopictus is 
monitored using ovitraps placed along the French 
Mediterranean coastline and land inwards along 
motorways. Traps are checked at least monthly for 
presence of Ae. albopictus eggs. Mosquitoes and eggs 
are not tested routinely for the presence of dengue and 
chikungunya viruses.
The administrative districts, according to the year of 
establishment of Ae. albopictus, are shown in Figure 1: 
from one district in 2004, Ae. albopictus  has become 
established in 18 administrative districts in six regions 
(Provence-Alpes-Côte d’Azur, Corsica, Languedoc-
Roussillon, Rhône-Alpes, Aquitaine, Midi-Pyrénées) in 
2014.
Figure 1
Establishment of Aedes albopictus, by administrative district and year, mainland France, 2004–2014
Source: IGN-GéoFLA, 1999: French Institute for Public Health Surveillance (Institut de Veille Sanitaire, InVS), 2014. ±
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Epidemiological surveillance for 
chikungunya and dengue
A suspected case is defined as a person with acute 
fever (>38.5 °C) and joint pains (chikungunya) or at least 
one of the following symptoms: headache, retro-orbital 
pain, joint pains, myalgia or lower back-pain (dengue), 
not explained by another medical condition. For both 
diseases, cases are confirmed by serology (IgM posi-
tive or a fourfold increase in IgG titre) or detection 
of viral nucleic acids in plasma by real-time reverse 
transcription polymerase chain reaction (RT-PCR), or 
for dengue, a positive dengue nonstructural protein 1 
(NS1) antigenic test.
The surveillance system aims to prevent or to contain 
autochthonous transmission of dengue and chikungu-
nya, and comprises three components:
•	 nationwide year-long mandatory notification of 
laboratory-confirmed cases of chikungunya and 
dengue;
•	 seasonal enhanced surveillance in the adminis-
trative districts where the vector is established. 
From May to November, when the vector is active, 
all suspected imported cases must be immedi-
ately reported to the regional health authorities 
(Agences Régionales de Santé, ARS). Appropriate 
vector control measures are then implemented 
within 200 metres of the places visited by the 
patients during the likely viraemic period (from 
the day before until seven days after the onset of 
symptoms [11]), without waiting for laboratory con-
firmation of the infection;
•	 daily reporting from a network of laboratories 
of the results of chikungunya and dengue sero-
logical or RT-PCR tests to the French Institute of 
Public Health Surveillance (Institut de veille sani-
taire, InVS). This catches cases who have not been 
reported through the notification system and the 
seasonal enhanced surveillance, and thus serves 
to improve the completeness of reporting of the 
surveillance system.
The notification of a laboratory-confirmed locally 
acquired case triggers immediate epidemiological and 
entomological investigations, in order to assess the 
Figure 2
Laboratory-confirmed imported chikungunya cases in mainland Francea, laboratory-confirmed imported chikungunya 
cases in Aedes albopictus-established districts in mainland France during the period of vector activityb and estimated 
number of clinically compatible chikungunya cases in the French Caribbeanc 
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a Per week, week 45 2013 to week 26 2014 (1 November 2013 to 27 June 2014), source: laboratory network. Data for week 26 2014 are not yet 
consolidated and are not available for week 27 2014.
b Per week, weeks 18 to 27 2014 (2 May to 4 July 4 2014), source: enhanced surveillance.
c Per week, week 48 2013 to week 26 2014 (25 November 2013 to 29 June 2014). Data are not available for week 27 2014, source: French 
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autochthonous transmission and to guide vector con-
trol measures. The investigation and control measures 
include: (i) active case finding in the neighbourhood of 
the case’s residence and in other areas visited by the 
case; (ii) recommending personal protection measures 
for the viraemic patient; (iii) encouraging health pro-
fessionals to screen suspected cases; (iv) carrying out 
perifocal vector control activities, within 200 metres 
of the case’s residence, including destruction of mos-
quito breeding sites and spraying targeted at adult 
mosquitoes; (v) giving information to the public about 
personal protection and reduction of mosquito breed-
ing sites.
Chikungunya cases in mainland France
Throughout mainland France, 475 laboratory-con-
firmed imported cases of chikungunya were notified 
through the laboratory network from 1 November 2013 
(the month of confirmation of the first cases in Saint 
Martin) to 27 June 2014 (Figure 2), whereas during the 
whole of 2011 and 2012, there were 33 and 17 cases, 
respectively.
From 2 May to 4 July 2014, of 350 suspected cases who 
were notified to the regional health authorities, 126 
were laboratory-confirmed imported cases of chikun-
gunya and 47 laboratory-confirmed imported cases of 
dengue were detected in the Ae. albopictus-established 
districts (Table 1 and Figure 2). A large majority of the 
laboratory-confirmed imported cases of chikungunya 
arrived from the French Caribbean (85% (107/126), as 
shown in Table 2). More than 80% of cases (n=103) 
were in an Ae.  albopictus-established district while 
potentially viraemic (the remaining 20% were diag-
nosed retrospectively). No autochthonous case has 
been confirmed to date. More information and updated 
surveillance results are provided on the InVS website 
[4].
Discussion
From 2006 to 2013, the number of laboratory-con-
firmed imported cases of chikungunya reported in Ae. 
albopictus-established districts from May to November 
ranged from 2 to 6 [4]. From 2 May to 4 July 2014, the 
number of laboratory-confirmed imported cases of 
chikungunya was much higher (126) than in previous 
years, as a consequence of the chikungunya outbreak 
in the Caribbean region.
Although no autochthonous case has been confirmed 
to date in 2014, the conditions required for autoch-
thonous transmission of the chikungunya virus are 
met: the population in mainland France is immunologi-
cally naive to the virus; a competent vector exists, Ae. 
albopictus [5] and its distribution has been constantly 
and rapidly spreading for the past 10 years [10]; and 
the probability of introduction of the virus by travel-
lers coming from affected areas is high. The possibility 
of occurrence of autochthonous transmission of arbo-
viruses has been demonstrated in the recent past in 
southern France, with the identification of two autoch-
thonous dengue cases in 2010 and one in 2013, as 
well as two autochthonous chikungunya cases in 2010 
[12-14].
Passenger traffic between mainland France and 
Martinique and Guadeloupe is high, with more than 2.5 
million plane passengers in 2013 [15]. During this sum-
mer of 2014 – when the mosquito is active – large num-
bers of travellers will return from the French Caribbean 
islands where an outbreak is currently occurring. 
Among them, a high proportion will possibly be virae-
mic upon their arrival, increasing the probability of the 
occurrence of autochthonous cases of chikungunya 
in the administrative districts where Ae. albopictus is 
established, and increasing the risk of a chikungunya 
outbreak in mainland France.
Table 1
Suspected and laboratory-confirmed cases of chikungunya and dengue, by region involved in seasonal enhanced surveillance, 
mainland France, 2 May–4 July (weeks 18 to 27) 2014 
Regions
Number of 
administrative 
districts 
where Aedes 
albopictus is 
established
Resident 
population in 
administrative 
districts where 
the vector is 
establisheda
Number of 
suspected 
cases
Number of 
laboratory-confirmed
imported cases
Number of 
laboratory-confirmed
autochthonous cases
Chikungunya Dengue Chikungunya Dengue
Provence-Alpes-Côte d'Azur 5 4,777,464 121 43 17 0 0
Corsica 2 314,486 4 0 0 0 0
Languedoc-Roussillon 4 2,592,890 55 28 6 0 0
Rhône-Alpes 4 3,764,718 76 27 12 0 0
Aquitaine 2 1,794,528 31 14 5 0 0
Midi-Pyrénées 1 1,260,226 63 14 7 0 0
Total 18 14,504,312 350 126 47 0 0
a Source: French national institute of economic and statistical information (Institut national de la statistique et des études économiques, 
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The preparedness and response plan developed in 
mainland France since 2006 has proved to be effec-
tive for the early detection of cases and implementa-
tion of vector control measures to prevent or contain 
autochthonous transmission of dengue and chikungu-
nya viruses. However, it is currently challenged by the 
increased number of imported chikungunya cases. It 
is thus crucial to maintain a high level of mobilisation 
of all actors within the surveillance system. They are 
also an important source of information for the general 
population, to encourage the use of personal protec-
tion against mosquito bites and control of mosquito 
breeding sites.
The challenge that we face is to avoid the establish-
ment of a local cycle of transmission in mainland France 
and, beyond, in other European areas where competent 
vectors are also present.
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Table 2
Laboratory-confirmed chikungunya cases imported to 
mainland France, by place of origin, as of 4 July (week 27) 
2014 
Place of origin Number of cases imported to 
mainland France
Guadeloupe   70
Martinique   36
Haiti   10
Dominican Republic   3
Tonga   1
Sierra Leone   1
Saint Martin   1
Indonesia   1
Côte d’Ivoire 1
Costa Rica   1
Cambodia   1
Total 126
Source: seasonal enhanced surveillance system, mainland France.